Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think Tank
Open Access
- 12 July 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 77 (12) , 1635-1643
Abstract
While the coronavirus disease 2019 (COVID-19) pandemic continues to present global challenges, sufficient time has passed to reflect on lessons learned and use those insights to inform policy and approaches to prepare for the next pandemic. In May 2022, the Duke Clinical Research Institute convened a think tank with thought leaders from academia, clinical practice, the pharmaceutical industry, patient advocacy, the National Institutes of Health, the US Food and Drug Administration, and the Centers for Disease Control and Prevention to share, firsthand, expert knowledge of the insights gained from the COVID-19 pandemic and how this acquired knowledge can help inform the next pandemic response. The think tank focused on pandemic preparedness, therapeutics, vaccines, and challenges related to clinical trial design and scale-up during the early phase of a pandemic. Based on the multi-faceted discussions, we outline 10 key steps to an improved and equitable pandemic response.Keywords
Funding Information
- Duke Clinical Research Institute
- DCRI (K24DA034621)
This publication has 12 references indexed in Scilit:
- Clinical Trial Participation and COVID-19: a Descriptive Analysis from the American Heart Association’s Get With The Guidelines RegistryJournal of Racial and Ethnic Health Disparities, 2022
- Implementation of platform trials in the COVID-19 pandemic: A rapid reviewContemporary Clinical Trials, 2021
- Integrating Research into Community Practice — Toward Increased Diversity in Clinical TrialsNew England Journal of Medicine, 2021
- Decentralized Clinical TrialsJACC: Basic To Translational Science, 2021
- Effect and Reach of Medical Articles Posted on Preprint Servers During the COVID-19 PandemicJAMA Internal Medicine, 2021
- Trends in COVID-19 therapeutic clinical trialsNature Reviews Drug Discovery, 2021
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial ResultsNew England Journal of Medicine, 2021
- The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deploymentJournal of the American Medical Informatics Association, 2020
- Vaccines don’t save lives. Vaccinations save livesHuman Vaccines & Immunotherapeutics, 2019
- The ADAPTABLE Trial and PCORnet: Shining Light on a New Research ParadigmAnnals of Internal Medicine, 2015